Skip to main content
. 2010 Jun 10;1(2):131–147. doi: 10.18632/oncotarget.117

Figure 3. MARY-X coinjection immunocytochemical studies.

Figure 3.

(A) Immunocytochemical studies of an extirpated tumor coinjected with GFP-labeled MEFs reveals tumoral nodules surrounded by encircling GFP immunoreactivity. Identical results were observed when the spheroids were coinjected with GFP-HMS-1. (B) Higher magnification of these tumoral nodules reveals their location within a space containing GFP immunoreactivity in its lining and luminal erythrocytes (arrows).